EUVIMEDEUVIMED entdecken
Crossref

Optical Control of Leukotriene A4 Hydrolase Using Photoswitchable Inhibitors

Xin Zhou, Shumei Wang, Xingye Yang iD, Xin Zhang, Zhao Ma iD, Lupei Du iD, Minyong Li iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.5c01654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Xin Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (MOE), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong…. Hauptthemen laut MEDLINE: Epoxide Hydrolases, Enzyme Inhibitors, Azo Compounds. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Taishan Scholar Foundation of Shandong Province, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leukotriene A4 hydrolase (LTA4H) is a prominent therapeutic target for leukotriene-associated inflammatory diseases, including cardiovascular diseases, asthma, and various tumor types. Using light to modulate LTA4H activity precisely is a leading approach to intervening in these inflammatory diseases. In this study, we utilized the azobenzene moiety to replace the diphenyl ether scaffold in LYS006, an LTA4H inhibitor developed by Novartis. We synthesized ten azobenzene-based photoswitchable LTA4H inhibitors with suitable photochemical properties. According to the enzymatic inhibitory assay, piLTA4H-1 was screened out since it significantly increases (∼150-fold) in inhibiting LTA4H when the condition changes from dark to 365 nm light exposure. Photoswitchable piLTA4H-1 could effectively modulate the eicosanoid release in mouse whole blood and enable the smart and effective intervention of arachidonic acid-induced ear dermatitis in mice. Optical control of LTA4H with piLTA4H-1 represents a promising strategy for inflammation intervention both in vitro and in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epoxide HydrolasesEnzyme InhibitorsAzo CompoundsAnimalsMiceHumansStructure-Activity RelationshipLight

Substanzen

Epoxide Hydrolasesleukotriene A4 hydrolaseEnzyme InhibitorsAzo Compounds

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (MOE), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China.
  • Pharmaceutical College, Guangxi Key Laboratory of Pharmaceutical Precision Detection and Screening, Key Laboratory of Micro-Nanoscale Bioanalysis and Drug Screening of Guangxi Education Department, Guangxi Key Laborator…
  • Key Laboratory of Tropical Biological Resources (MOE), School of Pharmaceutical Sciences, Hainan University, Haikou, Hainan 570228, China.

ORCID-Profile: Xingye Yang, Zhao Ma, Lupei Du, Minyong Li

Förderung

  • Taishan Scholar Foundation of Shandong Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Zhou, X., Wang, S., Yang, X., Zhang, X., Ma, Z., Du, L., & Li, M. (2025). Optical Control of Leukotriene A4 Hydrolase Using Photoswitchable Inhibitors. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c01654

Vancouver

Zhou X, Wang S, Yang X, Zhang X, Ma Z, Du L, et al. Optical Control of Leukotriene A4 Hydrolase Using Photoswitchable Inhibitors. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c01654

BibTeX
@article{Zhou2025,
  author = {Zhou, Xin and Wang, Shumei and Yang, Xingye and Zhang, Xin and Ma, Zhao and Du, Lupei and Li, Minyong},
  title = {Optical Control of Leukotriene A4 Hydrolase Using Photoswitchable Inhibitors},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.5c01654}
}
Kostenlos starten →